Breast cancer in men

SH Giordano - New England Journal of Medicine, 2018 - Mass Medical Soc
Breast Cancer in Men Breast cancer in men accounts for about 1% of all breast cancers and
is mainly estrogen-receptor–positive. Few prospective studies of treatment in men have …

Hereditary breast cancer: the era of new susceptibility genes

P Apostolou, F Fostira - BioMed research international, 2013 - Wiley Online Library
Breast cancer is the most common malignancy among females. 5%–10% of breast cancer
cases are hereditary and are caused by pathogenic mutations in the considered reference …

[HTML][HTML] Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined …

A Antoniou, PDP Pharoah, S Narod, HA Risch… - The American Journal of …, 2003 - cell.com
Germline mutations in BRCA1 and BRCA2 confer high risks of breast and ovarian cancer,
but the average magnitude of these risks is uncertain and may depend on the context …

Breast and Ovarian Cancer Risks Due to Inherited Mutations in BRCA1 and BRCA2

MC King, JH Marks, JB Mandell - Science, 2003 - science.org
Risks of breast and ovarian cancer were determined for Ashkenazi Jewish women with
inherited mutations in the tumor suppressor genes BRCA1 and BRCA2. We selected 1008 …

Epidemiology of breast cancer

TJ Key, PK Verkasalo, E Banks - The lancet oncology, 2001 - thelancet.com
Breast cancer is the commonest cause of cancer death in women worldwide. Rates vary
about five-fold around the world, but they are increasing in regions that until recently had low …

Gene-expression profiles in hereditary breast cancer

I Hedenfalk, D Duggan, Y Chen… - … England Journal of …, 2001 - Mass Medical Soc
Background Many cases of hereditary breast cancer are due to mutations in either the
BRCA1 or the BRCA2 gene. The histopathological changes in these cancers are often …

Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: a kin–cohort study in Ontario, Canada

HA Risch, JR McLaughlin, DEC Cole… - Journal of the …, 2006 - academic.oup.com
Background: BRCA1 and BRCA2 mutations in general populations and in various types of
cancers have not been well characterized. We investigated the presence of these mutations …

Incidence of gastric cancer and breast cancer in CDH1 (E-cadherin) mutation carriers from hereditary diffuse gastric cancer families

PDP Pharoah, P Guilford, C Caldas… - Gastroenterology, 2001 - Elsevier
BACKGROUND & AIMS:: Germline mutations in CDH1 are known to cause hereditary
diffuse gastric cancer (HDGC). Breast and colorectal cancer have also been reported in …

High-throughput proteomics and AI for cancer biomarker discovery

Q Xiao, F Zhang, L Xu, L Yue, OL Kon, Y Zhu… - Advanced drug delivery …, 2021 - Elsevier
Biomarkers are assayed to assess biological and pathological status. Recent advances in
high-throughput proteomic technology provide opportunities for developing next generation …

[HTML][HTML] Hereditary breast and ovarian cancer due to mutations in BRCA1 and BRCA2

N Petrucelli, MB Daly, GL Feldman - Genetics in Medicine, 2010 - Elsevier
Hereditary breast and ovarian cancer due to mutations in the BRCA1 and BRCA2 genes is
the most common cause of hereditary forms of both breast and ovarian cancer. The overall …